Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68GaNOTA-Anti-HER2 VHH1 in Brain Metastasis
NCT03331601Phase 2Terminated
- Sponsor
- UZ Brussel
- Start
- Oct 2017
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
A Phase 2 trial of [68Ga]Ga-NOTA-ABSCINT-HER2 in brain metastasis (BM), sponsored by UZ Brussel. Started Oct 2017; status: terminated.
02
Drugs
[68Ga]Ga-NOTA-ABSCINT-HER2
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT03331601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331601.